Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Withdrawn before enrolling · Phase 4
Conditions studied: Type 1 Diabetes
In brief
In this pilot study we are evaluating the efficacy of pramlintide on preventing weight gain among early onset type 1 diabetes. We are also evaluating the safety and the effects of treatment with pramlintide on early diagnosed type 1 diabetic subjects, especially among pediatric subjects.
Key facts
- Study ID
- NCT00505882
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 0
- Starts
- 2007-07-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2019-01-08
Who can join
Age: 12 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 12 to 40 years old
- Type 1 diabetes
- Fasting C-peptide ≤ 1.0 ng/ml
- Early diagnosed type 1 diabetes. (<6 months since diagnosis of type 1 diabetes.)
- HbA1c greater than 7.0 %
- Male, or If female, is nonlactating and has a negative pregnancy test (human chorionic gonadotropin, beta subunit [βhCG]) at Visit 1 (screening).
You may not qualify if…
- Has a clinically significant medical condition that could potentially affect study participation and/or personal well-being, as judged by the investigator, including but not limited to the following conditions:
- Hepatic disease
- Gastrointestinal disease
- Haematologic disorder
- Cardiovascular disorder
- Organ transplantation
- Hemochromatosis
- HIV, HBV, or HCV infection
- Abuses drugs or alcohol or has a history of abuse
- Eating disorder
- Has donated blood within 60 days
- Has had major surgery or a blood transfusion within 2 months
- Usage of medications that affect weight changes
- Use of medications that affect gastrointestinal motility
- Usage of medications that affect glucose/insulin metabolism
- Received any study medication or has participated in any type of clinical trial within 30 days prior to screening.
- Has known allergies or hypersensitivity to any component of study treatment.
Where it is running
- UT Southwestern at Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.